These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10869282)

  • 21. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS; Riely CA; Madan AK
    Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty liver--current look at the old disease.
    Mach T
    Med Sci Monit; 2000; 6(1):209-16. PubMed ID: 11208312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.
    Bradbury MW
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G194-8. PubMed ID: 16407588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B; Stremmel W
    Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and the liver: developmental perspectives.
    Hoppin AG
    Semin Liver Dis; 2004 Nov; 24(4):381-7. PubMed ID: 15605306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
    Parekh S; Anania FA
    Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Associated risk factors of fatty liver in the patients with type 2 diabetes mellitus].
    Chen QK; Chen HY; Wang LY; Zeng ZY; Zhou XD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):414-6. PubMed ID: 15268806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Other disease associations with non-alcoholic fatty liver disease (NAFLD).
    Allard JP
    Best Pract Res Clin Gastroenterol; 2002 Oct; 16(5):783-95. PubMed ID: 12406445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic fatty liver.
    Nagi DK; Vani DH
    Diabet Med; 2005 Jan; 22 Suppl 1():14-8. PubMed ID: 15610151
    [No Abstract]   [Full Text] [Related]  

  • 33. [Epidemiology of type 2 diabetes, is it a problem of bad nutrition or malnutrition?].
    Pinget M
    Soins; 2008 Apr; (724 Suppl):S4-8. PubMed ID: 18496971
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of nutrition and obesity on chronic liver disease.
    Manne V; Saab S
    Clin Liver Dis; 2014 Feb; 18(1):205-18. PubMed ID: 24274875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasonographic evaluation of hepatic steatosis in malnutrition.
    Lalwani SG; Karande S; Khemani R; Jain MK
    Indian Pediatr; 1998 Jul; 35(7):650-2. PubMed ID: 10216675
    [No Abstract]   [Full Text] [Related]  

  • 36. Nutrition and the liver.
    Kirsch RE; Saunders SJ
    S Afr Med J; 1972 Dec; 46(52):2072-8. PubMed ID: 4197215
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease.
    Bayard M; Holt J; Boroughs E
    Am Fam Physician; 2006 Jun; 73(11):1961-8. PubMed ID: 16770927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease.
    Moschen AR; Tilg H
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):620-5. PubMed ID: 18685459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutrition and metabolism: nutritional therapy for disordered triglyceride metabolism and nonalcoholic fatty liver disease.
    Watts GF
    Curr Opin Lipidol; 2010 Dec; 21(6):545-7. PubMed ID: 21206342
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nonalcoholic steatohepatitis (NASH): therapeutic approaches].
    Buscher HP
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S60-2. PubMed ID: 15368170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.